CN103333270B - Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage - Google Patents
Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage Download PDFInfo
- Publication number
- CN103333270B CN103333270B CN201310275413.6A CN201310275413A CN103333270B CN 103333270 B CN103333270 B CN 103333270B CN 201310275413 A CN201310275413 A CN 201310275413A CN 103333270 B CN103333270 B CN 103333270B
- Authority
- CN
- China
- Prior art keywords
- sodium alginate
- collagen peptide
- sulfuric ester
- sodium
- alginate sulfuric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000010413 sodium alginate Nutrition 0.000 title claims abstract description 85
- 229940005550 sodium alginate Drugs 0.000 title claims abstract description 85
- 239000000661 sodium alginate Substances 0.000 title claims abstract description 85
- 102000008186 Collagen Human genes 0.000 title claims abstract description 82
- 108010035532 Collagen Proteins 0.000 title claims abstract description 82
- 229920001436 collagen Polymers 0.000 title claims abstract description 82
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 title claims abstract description 79
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 150000002148 esters Chemical class 0.000 title claims 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- 239000011734 sodium Substances 0.000 claims abstract description 13
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 5
- 230000003213 activating effect Effects 0.000 claims abstract description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 18
- 239000012190 activator Substances 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 12
- 238000006467 substitution reaction Methods 0.000 claims description 12
- NASRDENTZCCAPN-UHFFFAOYSA-N OC([Na])=O Chemical compound OC([Na])=O NASRDENTZCCAPN-UHFFFAOYSA-N 0.000 claims description 5
- 230000035876 healing Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 230000037452 priming Effects 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 238000012805 post-processing Methods 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract description 58
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 18
- 230000029663 wound healing Effects 0.000 abstract description 13
- 210000002950 fibroblast Anatomy 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 206010052428 Wound Diseases 0.000 description 19
- 239000007987 MES buffer Substances 0.000 description 13
- 238000003760 magnetic stirring Methods 0.000 description 12
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003402 anti-promotion Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000014508 negative regulation of coagulation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明属高分子化学材料领域,具体涉及一种胶原蛋白肽接枝海藻酸钠硫酸酯、制备方法及其用途。胶原蛋白肽接枝海藻酸钠硫酸酯,它是将海藻酸钠硫酸酯的羧基钠基团进行活化后再与胶原蛋白肽25-65℃进行接枝反应得到的。该方法制备工艺简单,制得的胶原蛋白肽接枝海藻酸钠硫酸酯具有良好的清除过氧化氢、促进成纤维细胞增殖的性能,能显著促进伤口创面的愈合。
The invention belongs to the field of macromolecular chemical materials, and in particular relates to a collagen peptide grafted with sodium alginate sulfate, a preparation method and an application thereof. Collagen peptide is grafted with sodium alginate sulfate, which is obtained by activating the sodium carboxylate group of sodium alginate sulfate and then grafting reaction with collagen peptide at 25-65°C. The preparation process of the method is simple, and the prepared collagen peptide grafted with sodium alginate sulfate has good properties of removing hydrogen peroxide and promoting proliferation of fibroblasts, and can significantly promote wound healing.
Description
技术领域technical field
本发明属高分子化学材料领域,具体涉及一种胶原蛋白肽接枝海藻酸钠硫酸酯、制备方法及其用途。The invention belongs to the field of macromolecular chemical materials, and in particular relates to a collagen peptide grafted with sodium alginate sulfate, a preparation method and an application thereof.
背景技术Background technique
海藻酸钠骨架上分布有许多自由羟基和羧基钠基团,是理想的化学改性物质。海藻酸钠硫酸酯是对海藻酸钠的羟基进行磺化改性后的产物。与海藻酸钠相比,海藻酸钠硫酸酯不仅保留了海藻酸钠的生物相容性、无毒、非免疫原性等性质,还具有良好的水溶性,降糖作用,抗凝血性,抗氧化,抗肿瘤作用,抗炎作用和促进细胞增殖等性能。海藻酸钠硫酸酯结构类似于肝素,具有一定的抗凝血活性,能以类似于肝素的方式促进伤口愈合。由于溶解性的改善,使海藻酸钠硫酸酯的应用范围更加广泛,在食品,医药等方面都有很多应用。胶原蛋白肽是胶原蛋白的水解产物,易被人体吸收,有极好的亲水性、吸湿保湿性。如可将胶原蛋白肽接枝与海藻酸钠硫酸酯上,其将在伤口愈合上发挥更好地作用。.There are many free hydroxyl groups and sodium carboxylate groups distributed on the skeleton of sodium alginate, which is an ideal chemical modification substance. Sodium alginate sulfate is the product of sulfonation modification of the hydroxyl group of sodium alginate. Compared with sodium alginate, sodium alginate sulfate not only retains the biocompatibility, non-toxic, non-immunogenic properties of sodium alginate, but also has good water solubility, hypoglycemic effect, anticoagulant, anti Oxidation, anti-tumor effect, anti-inflammatory effect and promotion of cell proliferation and other properties. Sodium alginate sulfate has a structure similar to heparin, has certain anticoagulant activity, and can promote wound healing in a manner similar to heparin. Due to the improvement of solubility, the application range of sodium alginate sulfate is wider, and it has many applications in food and medicine. Collagen peptide is a hydrolyzed product of collagen, which is easily absorbed by the human body and has excellent hydrophilicity, moisture absorption and moisturizing properties. If collagen peptides can be grafted onto sodium alginate sulfate, it will play a better role in wound healing. .
发明内容Contents of the invention
本发明所要解决的技术问题是提供胶原蛋白肽接枝海藻酸钠硫酸酯、制备方法及其用途。该方法制备工艺简单,制得的胶原蛋白肽接枝海藻酸钠硫酸酯具有良好的清除过氧化氢、促进成纤维细胞增殖的性能,能显著促进伤口创面的愈合。The technical problem to be solved by the present invention is to provide collagen peptide grafted with sodium alginate sulfate, a preparation method and use thereof. The preparation process of the method is simple, and the prepared collagen peptide grafted with sodium alginate sulfate has good properties of removing hydrogen peroxide and promoting proliferation of fibroblasts, and can significantly promote wound healing.
为解决上述技术问题,本发明提供的技术方案是:In order to solve the problems of the technologies described above, the technical solution provided by the invention is:
胶原蛋白肽接枝海藻酸钠硫酸酯,其特征在于:它是将海藻酸钠硫酸酯的羧基钠基团进行活化后再与胶原蛋白肽25-65℃进行接枝反应得到的。The collagen peptide grafted with sodium alginate sulfate is characterized in that it is obtained by activating the sodium carboxylate group of the sodium alginate sulfate and then grafting the collagen peptide at 25-65°C.
按上述方案,所述胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为0.062-0.469,优选为0.124-0.469,更优选为0.228-0.469。According to the above scheme, the substitution degree of the sodium carboxylate group in the collagen peptide grafted with sodium alginate sulfate is 0.062-0.469, preferably 0.124-0.469, more preferably 0.228-0.469.
本发明还提供了上述胶原蛋白肽接枝海藻酸钠硫酸酯的制备方法。The present invention also provides a preparation method of the collagen peptide grafted with sodium alginate sulfate.
胶原蛋白肽接枝海藻酸钠硫酸酯的制备方法,其特征在于:它是先将海藻酸钠硫酸酯的羧基钠基团与羧基活化剂经活化反应后,再与胶原蛋白肽25-65℃进行接枝反应、后处理。The preparation method of collagen peptide grafted with sodium alginate sulfate is characterized in that: firstly, the sodium carboxylate group of sodium alginate sulfate is activated and reacted with carboxyl activator, and then it is mixed with collagen peptide at 25-65°C Grafting reaction and post-treatment are carried out.
按上述方案,所述的活化反应是在pH为5-7的条件下将海藻酸钠硫酸酯与羧基活化剂在25-65℃下反应12-28小时,所述的羧基活化剂为1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)的混合物。According to the above scheme, the activation reaction is to react sodium alginate sulfate with carboxyl activator at 25-65°C for 12-28 hours under the condition of pH 5-7, and the carboxyl activator is 1- Mixture of (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS).
按上述方案,所述的活化反应中海藻酸钠硫酸酯是先用pH为5-7的2-(N-吗啉代)乙磺酸(MES)缓冲溶液溶解后,再加入羧基活化剂进行反应。According to the above scheme, the sodium alginate sulfate in the activation reaction is firstly dissolved with a 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution with a pH of 5-7, and then a carboxyl activator is added. reaction.
按上述方案,所述羧基活化剂中1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)的质量比为3.3:1-6.7:1;所述N-羟基琥珀酰亚胺(NHS)与海藻酸钠硫酸酯的质量比为0.2:1-0.6:1。According to the above scheme, the mass of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) in the carboxyl activator The ratio is 3.3:1-6.7:1; the mass ratio of N-hydroxysuccinimide (NHS) to sodium alginate sulfate is 0.2:1-0.6:1.
按上述方案,所述海藻酸钠硫酸酯的硫酸酯(SO3Na)取代度为1-1.8。According to the above scheme, the degree of substitution of sodium alginate sulfate (SO 3 Na) is 1-1.8.
按上述方案,所述胶原蛋白肽与海藻酸钠硫酸酯的质量比为0.4:1-2.0:1。According to the above scheme, the mass ratio of the collagen peptide to sodium alginate sulfate is 0.4:1-2.0:1.
按上述方案,所述加入胶原蛋白肽后进行接枝反应的反应时间为10-30min。According to the above scheme, the reaction time for the grafting reaction after adding the collagen peptide is 10-30 minutes.
按上述方案,所述的后处理为加入胶原蛋白肽反应完成后透析,纯化,干燥。According to the above scheme, the post-treatment is dialysis, purification and drying after the completion of the reaction by adding collagen peptides.
按上述方案,所述的胶原蛋白肽接枝海藻酸钠硫酸酯在伤口创面愈合中的应用。According to the above scheme, the application of the collagen peptide grafted with sodium alginate sulfate in wound healing.
本发明的有益效果:本发明制备工艺简单,成本低廉,环境友好,功能显著;制备的胶原蛋白肽接枝海藻酸钠硫酸酯水溶性好,可清除过氧化氢并能促进成纤维细胞增殖,能显著地促进伤口创面的愈合。Beneficial effects of the present invention: the preparation process of the present invention is simple, low in cost, environment-friendly and remarkable in function; the prepared collagen peptide grafted with sodium alginate sulfate has good water solubility, can remove hydrogen peroxide and can promote fibroblast proliferation, Can significantly promote wound healing.
附图说明Description of drawings
图1为实施例1制备的胶原蛋白肽接枝海藻酸钠硫酸酯的红外光谱图;Fig. 1 is the infrared spectrogram of the collagen peptide graft sodium alginate sulfate prepared in embodiment 1;
图2为实施例1-6制备的胶原蛋白肽接枝海藻酸钠硫酸酯对过氧化氢的清除率;Fig. 2 is the scavenging rate of hydrogen peroxide to the collagen peptide graft sodium alginate sulfate prepared by embodiment 1-6;
图3为实施例1、2、6制备的胶原蛋白肽接枝海藻酸钠硫酸酯及未接枝胶原蛋白肽的海藻酸钠硫酸酯对成纤维细胞的细胞存活率;Fig. 3 is the cell survival rate of the sodium alginate sulfate of the collagen peptide grafting sodium alginate sulfate prepared by embodiment 1,2,6 and ungrafted collagen peptide to fibroblast;
图4为实施例1的胶原蛋白肽接枝海藻酸钠硫酸酯对烧伤创面愈合影响的观察;Fig. 4 is the observation of the effect of the collagen peptide grafting sodium alginate sulfate of embodiment 1 on burn wound healing;
图5为实施例2的胶原蛋白肽接枝海藻酸钠硫酸酯对烧伤创面愈合影响的光学显微镜观察。5 is an optical microscope observation of the effect of collagen peptide grafted with sodium alginate sulfate in Example 2 on burn wound healing.
具体实施方式detailed description
以下结合具体的实例来进一步说明本发明。The present invention will be further described below in conjunction with specific examples.
实施例1Example 1
配制0.2mol/l的2-(N-吗啉代)乙磺酸(MES)缓冲溶液,并用0.3mol/l的氯化钠溶液调节其pH值至6.5。量取MES缓冲溶液50ml至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)0.40g和N-羟基琥珀酰亚胺(NHS)0.12g。在55℃下磁力搅拌20小时后,加入0.48g胶原蛋白肽,并继续磁力搅拌10min。将反应后的溶液透析三天纯化,冷冻干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为0.436。该胶原蛋白肽接枝海藻酸钠硫酸酯经红外表征的红外图谱见图1。图中:在1651cm-1和1555cm-1处出现的吸收峰,它们分别归属于酰胺Ⅰ带和酰胺Ⅱ带;在1245cm-1和875cm-1处出现的吸收峰分别归属于S=O键的伸缩振动吸收峰和C-O-S的振动吸收峰。Prepare 0.2mol/l 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution, and adjust its pH value to 6.5 with 0.3mol/l sodium chloride solution. Measure 50ml of MES buffer solution into a three-neck flask, add 0.6g of sodium alginate sulfate to fully dissolve it. Subsequently, 0.40 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.12 g of N-hydroxysuccinimide (NHS) were sequentially added. After magnetic stirring at 55° C. for 20 hours, 0.48 g of collagen peptide was added, and magnetic stirring was continued for 10 min. The reacted solution was purified by dialysis for three days, and then freeze-dried to obtain collagen peptide-grafted sodium alginate sulfate. It was determined that the sodium carboxyl group in the collagen peptide-grafted sodium alginate sulfate was replaced by collagen peptide The degree of substitution was 0.436. Figure 1 shows the infrared spectrum of the collagen peptide grafted with sodium alginate sulfate characterized by infrared. In the figure: the absorption peaks at 1651cm -1 and 1555cm -1 are assigned to the amide I band and the amide II band respectively; the absorption peaks at 1245cm -1 and 875cm -1 are respectively assigned to the S=O bond Stretching vibration absorption peak and COS vibration absorption peak.
实施例2Example 2
配制0.2mol/l的2-(N-吗啉代)乙磺酸(MES)缓冲溶液,并用0.3mol/l的氯化钠溶液调节其pH值至6.5。量取MES缓冲溶液50ml至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)0.60g和N-羟基琥珀酰亚胺(NHS)0.18g。在45℃下磁力搅拌20小时后,加入1.2g胶原蛋白肽,并继续磁力搅拌10min。将反应后的溶液透析三天纯化,冷冻干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为为0.310。Prepare 0.2mol/l 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution, and adjust its pH value to 6.5 with 0.3mol/l sodium chloride solution. Measure 50ml of MES buffer solution into a three-neck flask, add 0.6g of sodium alginate sulfate to fully dissolve it. Subsequently, 0.60 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.18 g of N-hydroxysuccinimide (NHS) were added in sequence. After magnetic stirring at 45° C. for 20 hours, 1.2 g of collagen peptide was added, and magnetic stirring was continued for 10 min. The reacted solution was purified by dialysis for three days, and then freeze-dried to obtain collagen peptide-grafted sodium alginate sulfate. It was determined that the sodium carboxyl group in the collagen peptide-grafted sodium alginate sulfate was replaced by collagen peptide The degree of substitution was 0.310.
实施例3Example 3
配制pH6.5的2-(N-吗啉代)乙磺酸(MES)缓冲溶液,然后量取适量该MES缓冲溶液至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)1.19g和N-羟基琥珀酰亚胺(NHS)0.36g。在35℃下磁力搅拌12小时后,加入0.48g胶原蛋白肽,并继续磁力搅拌反应。将反应后的溶液透析、纯化、干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为为0.062。Prepare 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution at pH 6.5, then measure an appropriate amount of the MES buffer solution into a three-necked flask, add 0.6g of sodium alginate sulfate to fully dissolve it. Subsequently, 1.19 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.36 g of N-hydroxysuccinimide (NHS) were sequentially added. After 12 hours of magnetic stirring at 35 °C, 0.48 g of collagen peptide was added, and the magnetic stirring reaction was continued. The solution after the reaction was dialyzed, purified, and dried to obtain collagen peptide grafted sodium alginate sulfate. After determination: the degree of substitution of the carboxyl sodium group in the collagen peptide grafted sodium alginate sulfate was replaced by collagen peptide is 0.062.
实施例4Example 4
配制0.2mol/l的2-(N-吗啉代)乙磺酸(MES)缓冲溶液,并用0.3mol/l的氯化钠溶液调节其pH值至6.5。量取MES缓冲溶液至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)0.40g和N-羟基琥珀酰亚胺(NHS)0.12g。在35℃下磁力搅拌24小时后,加入0.48g胶原蛋白肽,并继续磁力搅拌30min。将反应后的溶液透析三天纯化,冷冻干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为为0.359。Prepare 0.2mol/l 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution, and adjust its pH value to 6.5 with 0.3mol/l sodium chloride solution. Measure the MES buffer solution into a three-necked flask, and add 0.6 g of sodium alginate sulfate to fully dissolve it. Subsequently, 0.40 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.12 g of N-hydroxysuccinimide (NHS) were sequentially added. After magnetic stirring at 35° C. for 24 hours, 0.48 g of collagen peptide was added, and magnetic stirring was continued for 30 min. The reacted solution was purified by dialysis for three days, and then freeze-dried to obtain collagen peptide-grafted sodium alginate sulfate. It was determined that the sodium carboxyl group in the collagen peptide-grafted sodium alginate sulfate was replaced by collagen peptide The degree of substitution was 0.359.
实施例5Example 5
配制pH值5.5的2-(N-吗啉代)乙磺酸(MES)缓冲溶液。量取适量MES缓冲溶液至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)0.80g和N-羟基琥珀酰亚胺(NHS)0.12g。在35℃下磁力搅拌28小时后,加入0.24g胶原蛋白肽,并继续磁力搅拌20min。将反应后的溶液透析三天纯化,冷冻干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为为0.228。Prepare a buffer solution of 2-(N-morpholino)ethanesulfonic acid (MES) at pH 5.5. Measure an appropriate amount of MES buffer solution into a three-necked flask, and add 0.6 g of sodium alginate sulfate to fully dissolve it. Subsequently, 0.80 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.12 g of N-hydroxysuccinimide (NHS) were sequentially added. After magnetic stirring at 35° C. for 28 hours, 0.24 g of collagen peptide was added, and magnetic stirring was continued for 20 min. The reacted solution was purified by dialysis for three days, and then freeze-dried to obtain collagen peptide-grafted sodium alginate sulfate. It was determined that the sodium carboxyl group in the collagen peptide-grafted sodium alginate sulfate was replaced by collagen peptide The degree of substitution was 0.228.
实施例6Example 6
配制0.2mol/l的2-(N-吗啉代)乙磺酸(MES)缓冲溶液,并用0.3mol/l的氯化钠溶液调节其pH值至6.5。量取MES缓冲溶液50ml至三口烧瓶中,加入0.6g海藻酸钠硫酸酯,使其充分溶解。随后依次加入1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)1.19g和N-羟基琥珀酰亚胺(NHS)0.36g。在35℃下磁力搅拌20小时后,加入0.24g胶原蛋白肽,并继续磁力搅拌10min。将反应后的溶液透析三天纯化,冷冻干燥后得到胶原蛋白肽接枝海藻酸钠硫酸酯,经测定:该胶原蛋白肽接枝海藻酸钠硫酸酯中羧基钠基团被胶原蛋白肽取代的取代度为为0.124。Prepare 0.2mol/l 2-(N-morpholino)ethanesulfonic acid (MES) buffer solution, and adjust its pH value to 6.5 with 0.3mol/l sodium chloride solution. Measure 50ml of MES buffer solution into a three-neck flask, add 0.6g of sodium alginate sulfate to fully dissolve it. Subsequently, 1.19 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and 0.36 g of N-hydroxysuccinimide (NHS) were sequentially added. After magnetic stirring at 35° C. for 20 hours, 0.24 g of collagen peptide was added, and magnetic stirring was continued for 10 min. The reacted solution was purified by dialysis for three days, and then freeze-dried to obtain collagen peptide-grafted sodium alginate sulfate. It was determined that the sodium carboxyl group in the collagen peptide-grafted sodium alginate sulfate was replaced by collagen peptide The degree of substitution was 0.124.
将上述各实施例制备的胶原蛋白肽接枝海藻酸钠硫酸酯进行如下性能表征:The collagen peptide grafted sodium alginate sulfate prepared by each of the above-mentioned embodiments is characterized as follows:
(1)将实施例1-6制备的胶原蛋白肽接枝海藻酸钠硫酸酯分别配制成1mg/ml的溶液,作测试样品,然后与6.0ml的磷酸盐缓冲溶液(PBS,0.1mol/l,pH7.4)混合,加入1.0ml的双氧水(H2O2,40mmol/l)于上述混合液中,得各测试样品溶液。10min后,用紫外分光光度计测各测试样品溶液在230nm处的吸光度,按以下公式计算各实施例制备的胶原蛋白肽接枝海藻酸钠硫酸酯的过氧化氢清除率,结果见图2,其中As为测试样品溶液的吸光度,Ab为不加双氧水的测试样品溶液的吸光度,Ac为不加测试样品的样品溶液的吸光度。(1) The collagen peptides grafted with sodium alginate sulfate prepared in Examples 1-6 were respectively prepared into 1 mg/ml solutions as test samples, and then mixed with 6.0 ml of phosphate buffered saline solution (PBS, 0.1 mol/l , pH7.4) were mixed, and 1.0ml of hydrogen peroxide (H 2 O 2 , 40mmol/l) was added to the above mixed solution to obtain each test sample solution. After 10min, measure the absorbance of each test sample solution at 230nm with a UV spectrophotometer, calculate the hydrogen peroxide scavenging rate of the collagen peptide grafted sodium alginate sulfate prepared by each embodiment according to the following formula, the results are shown in Fig. 2, Wherein A s is the absorbance of the test sample solution, A b is the absorbance of the test sample solution without hydrogen peroxide, and A c is the absorbance of the sample solution without the test sample.
由图2可知:海藻酸钠硫酸酯经过胶原蛋白肽接枝改性后过氧化氢清除率增大,并随着取代度的增大而增大。适当清除氧自由基可以改善血管通透性,减少渗出液,减轻组织的水肿和细胞损伤,从而促进创面的加速愈合,而过氧化氢在体内可转变为氧自由基,因此良好的过氧化氢清除率将有利于伤口创面的愈合。It can be seen from Figure 2 that the hydrogen peroxide scavenging rate of sodium alginate sulfate increases after collagen peptide grafting modification, and increases with the increase of the degree of substitution. Proper scavenging of oxygen free radicals can improve vascular permeability, reduce exudate, reduce tissue edema and cell damage, thereby promoting accelerated wound healing, and hydrogen peroxide can be converted into oxygen free radicals in the body, so good peroxidation The hydrogen scavenging rate will be beneficial to the healing of the wound surface.
(2)将实施例1、2、6制备的胶原蛋白肽接枝海藻酸钠硫酸酯及未接枝胶原蛋白肽的海藻酸钠硫酸酯用于测定其对成纤维细胞的促进作用,实验步骤如下:(2) The collagen peptide grafted with sodium alginate sulfate prepared in Examples 1, 2, and 6 and the sodium alginate sulfate of ungrafted collagen peptide were used to determine their promoting effect on fibroblasts, the experimental procedure as follows:
在无菌条件下,将大鼠皮肤成纤维细胞置入培养瓶中,用含10%FBS的DMEM培养基在37℃、5%CO2的培养箱中培养。将传代3次后的成纤维细胞接种于96孔细胞培养板中(6000细胞/孔),用200μl含10%FBS的DMEM培养基培养24h。加入各实施例的胶原蛋白肽接枝海藻酸钠硫酸酯(测试样)或未接枝胶原蛋白肽的海藻酸钠硫酸酯(对比样)培养48h后,用含10%FBS的DMEM培养基替换随后加入20μl的MTT溶液,避光反应4h。吸去培养基后加入150μl二甲基亚砜(DMSO),反应10min,使MTT甲瓒晶体溶解。用酶标仪测其在492nm处的吸光度,按公式计算细胞存活率,结果见图3,其中As为测试样或对比样的吸光度,Ac为空白对照。Under sterile conditions, rat skin fibroblasts were placed in culture flasks and cultured in DMEM medium containing 10% FBS in an incubator at 37°C and 5% CO 2 . The fibroblasts after three passages were seeded in 96-well cell culture plates (6000 cells/well), and cultured with 200 μl DMEM medium containing 10% FBS for 24 hours. After adding the collagen peptide grafted sodium alginate sulfate (test sample) of each embodiment or the sodium alginate sulfate (comparative sample) without grafting collagen peptide and culturing for 48 hours, replace it with DMEM medium containing 10% FBS Subsequently, 20 μl of MTT solution was added and reacted in the dark for 4 hours. After aspirating the medium, add 150 μl dimethyl sulfoxide (DMSO) and react for 10 min to dissolve the MTT formazan crystals. The absorbance at 492nm was measured with a microplate reader, and the cell survival rate was calculated according to the formula. The results are shown in Figure 3, where A s is the absorbance of the test sample or the control sample, and A c is the blank control.
由图3可知:海藻酸钠硫酸酯经过胶原蛋白肽接枝改性后得到的各实施例中的胶原蛋白肽接枝海藻酸钠硫酸酯均表现出了较好的细胞存活率,并明显高于未接枝胶原蛋白肽的海藻酸钠硫酸酯,且随着取代度的增大,细胞存活率有升高的趋势。成纤维细胞在创面愈合过程中的增殖和分化对促进创面愈合起着重要作用,成纤维细胞存活率越大,创面愈合越快。It can be seen from Figure 3 that the collagen peptide-grafted sodium alginate sulfate in each embodiment obtained after the modification of sodium alginate sulfate by collagen peptide grafting showed better cell viability, and was significantly higher. Sodium alginate sulfate in ungrafted collagen peptides, and with the increase of the degree of substitution, the cell viability tended to increase. The proliferation and differentiation of fibroblasts in the process of wound healing play an important role in promoting wound healing, the greater the survival rate of fibroblasts, the faster the wound healing.
(3)将实施例1的胶原蛋白肽接枝海藻酸钠硫酸酯用于深Ⅱ度烧伤创面的愈合。(3) The collagen peptide grafted with sodium alginate sulfate in Example 1 was used for the healing of deep second-degree burn wounds.
将SD大鼠腹腔注射0.8ml的3%戊巴比妥钠,使其麻醉。背部用8%的硫化钠溶液脱毛。用恒温恒压电烫仪在SD大鼠背部烫15s,温度为75℃,造成面积为3.14cm2的深Ⅱ度烧伤创面。烧伤创面用体积比为1︰4的PVP-I和生理盐水稀释的碘伏消毒后,用浸胶原蛋白肽接枝海藻酸钠硫酸酯的油纱包扎创面,缝合线缝针固定,并包裹八层无菌纱布,自粘弹性绷带固定。每隔一天更换一次敷料。然后在烫伤当天,第3天,第7天和第14天分别进行观察,烫伤当天、第3天、第7天和第14天的创面愈合照片结果见图4,烫伤第7天和第14天的光学显微镜结果见图5。SD rats were anesthetized by intraperitoneal injection of 0.8ml of 3% pentobarbital sodium. The back was depilated with 8% sodium sulfide solution. A constant temperature and constant voltage electric scald was used to scald the backs of SD rats for 15 seconds at a temperature of 75°C, resulting in deep second-degree burn wounds with an area of 3.14 cm 2 . After the burn wound was sterilized with PVP-I with a volume ratio of 1:4 and povidone iodine diluted with normal saline, the wound was wrapped with oil gauze soaked in collagen peptide grafted with sodium alginate sulfate, fixed with sutures and needles, and wrapped eight times. A layer of sterile gauze, fixed with a self-adhesive elastic bandage. Change the dressing every other day. Then on the day of scalding, the 3rd day, the 7th day and the 14th day were observed respectively. The results of the wound healing photos on the day of scalding, the 3rd day, the 7th day and the 14th day are shown in Fig. The optical microscopy results of the day are shown in Figure 5.
由图4可看出:烫伤当天,肉眼可明显区分创面与正常区域,创面均呈圆形,创缘整体,边界清晰,创面苍白无生机,光泽差,轻度肿胀;伤后第3天,创面面积变小,创面干燥红润,皮薄痂薄,痂皮紧贴基底层,局部可见少许愈合的皮肤;伤后第7天,创面明显缩小,创面干燥红润,无渗出,痂皮与创面分离、脱落,可见有新生皮肤长出,爬皮速度较快;伤后第14天,创面生长良好,已被新生的上皮组织完全覆盖,无感染,无缝线反应,无红肿,烧伤创面完全愈合。It can be seen from Figure 4 that on the day of burn, the wound surface can be clearly distinguished from the normal area with the naked eye. The wound surface is round, the wound margin is overall, the boundary is clear, the wound surface is pale and lifeless, with poor luster and mild swelling; on the third day after injury, The area of the wound becomes smaller, the wound is dry and red, the skin is thin and the scab is close to the base layer, and a little healed skin can be seen locally; on the 7th day after injury, the wound shrinks significantly, the wound is dry and red, without exudation, the scab and the wound Separation and detachment, it can be seen that new skin grows, and the speed of skin climbing is fast; on the 14th day after injury, the wound grows well and has been completely covered by new epithelial tissue, no infection, no suture reaction, no redness, and the burn wound is completely heal.
由图5可看出:伤后第7天,毛细血管数量、纤维细胞、成纤维细胞、表皮细胞、炎症细胞明显增多,创面部分被表皮覆盖;伤后第14天,创面被表皮细胞覆盖,表皮愈合完全,胶原纤维排列整齐且与表皮平行,结缔组织纤维排布致密。这说明本发明的胶原蛋白肽接枝海藻酸钠硫酸酯对深Ⅱ度烧伤创面具有良好的愈合效果。It can be seen from Figure 5 that on the 7th day after injury, the number of capillaries, fibroblasts, fibroblasts, epidermal cells, and inflammatory cells increased significantly, and the wound was partially covered by epidermis; on the 14th day after injury, the wound was covered by epidermal cells, The epidermis healed completely, the collagen fibers were arranged neatly and parallel to the epidermis, and the connective tissue fibers were densely arranged. This shows that the collagen peptide grafted with sodium alginate sulfate of the present invention has a good healing effect on deep second-degree burn wounds.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310275413.6A CN103333270B (en) | 2013-07-02 | 2013-07-02 | Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310275413.6A CN103333270B (en) | 2013-07-02 | 2013-07-02 | Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103333270A CN103333270A (en) | 2013-10-02 |
CN103333270B true CN103333270B (en) | 2016-05-11 |
Family
ID=49241486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310275413.6A Active CN103333270B (en) | 2013-07-02 | 2013-07-02 | Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103333270B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103739734A (en) * | 2014-01-14 | 2014-04-23 | 武汉理工大学 | Carboxymethyl carrageenan-collagen peptide, and preparation method and use thereof |
CN118320166B (en) * | 2024-04-12 | 2024-10-29 | 四川大学 | Wound dressing and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1542021A (en) * | 2003-11-04 | 2004-11-03 | 武汉大学 | Sodium alginate sulfate and its preparation method and use |
CN101018513A (en) * | 2004-08-13 | 2007-08-15 | 渥太华健康研究所 | Vision enhancing ophthalmic devices and related methods and compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8361501B2 (en) * | 2004-09-30 | 2013-01-29 | Covalon Technologies, Inc. | Non-adhesive elastic gelatin matrices |
-
2013
- 2013-07-02 CN CN201310275413.6A patent/CN103333270B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1542021A (en) * | 2003-11-04 | 2004-11-03 | 武汉大学 | Sodium alginate sulfate and its preparation method and use |
CN101018513A (en) * | 2004-08-13 | 2007-08-15 | 渥太华健康研究所 | Vision enhancing ophthalmic devices and related methods and compositions |
Non-Patent Citations (2)
Title |
---|
"Study on gelatin-containing artificial skin:Ⅰ.Preparation and characteristics of novel gelatin-alginate sponge";Young Seon Choi et al.;《Biomaterials》;19990331;第20卷(第5期);第409-412,414-415页 * |
"褐藻酸钠硫酸酯的抗凝血及抗血栓作用";许实波等;《热带海洋》;19980630;第17卷(第2期);第32-37页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103333270A (en) | 2013-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Mussel-inspired collagen-hyaluronic acid composite scaffold with excellent antioxidant properties and sustained release of a growth factor for enhancing diabetic wound healing | |
Li et al. | Injectable and self-healing chitosan-based hydrogel with MOF-loaded α-lipoic acid promotes diabetic wound healing | |
CN102352051B (en) | Method for preparing collagen-modified bacteria cellulose compound film | |
CN102727926B (en) | The preparation method of the composite wound dressing of a kind of polysaccharide and nanometer bacteria cellulose | |
Guo et al. | Sulfonated, quaternized, and chlorogenic acid composited sodium alginate hydrogels/Eucommia ulmoides rubber films as in vitro antibacterial wound dressings for accelerating wound healing | |
Li et al. | Cellulose nanofibers embedded chitosan/tannin hydrogel with high antibacterial activity and hemostatic ability for drug-resistant bacterial infected wound healing | |
Han et al. | Hydrogen sulfide-releasing polyurethane/gelatin/keratin–TA conjugate mats for wound healing | |
US10456410B2 (en) | Hydrogen sulfide (H2S) releasing donor compound for dermal wound regeneration | |
CN116870243B (en) | Hydrogel with hemostatic and anti-inflammatory effects and preparation method and application thereof | |
CN111905143A (en) | A kind of multifunctional tissue adhesion crystal glue dressing and preparation method and application thereof | |
Zhang et al. | Water-retaining and separable adhesive hydrogel dressing for wound healing without secondary damage | |
CN115177778B (en) | Composite wound dressing, preparation method and application | |
Li et al. | Mussel-inspired methacrylated gelatin-dopamine/quaternized chitosan/glycerin sponges with self-adhesion, antibacterial activity, and hemostatic ability for wound dressings | |
Mo et al. | Protamine-grafted carboxymethyl chitosan based hydrogel with adhesive and long-term antibacterial properties for hemostasis and skin wound healing | |
CN100595208C (en) | Preparation method of sulfated silk fibroin and its application in anticoagulant drugs | |
CN103333270B (en) | Collagen peptide grafted sodium alginate sulfuric ester, preparation method and its usage | |
Rong et al. | Fetal milieu-simulating hyaluronic acid-dopamine-chondroitin sulfate hydrogel promoting angiogenesis and hair regeneration for wound healing | |
CN103819685A (en) | Fish scale collagen grafted chitosan as well as preparation method and application thereof | |
Wang et al. | Quaternized chitosan-based biomimetic nanozyme hydrogels with ROS scavenging, oxygen generating, and antibacterial capabilities for diabetic wound repair | |
CN108245700A (en) | A kind of hydroxypropyl methyl cellulose chitosan film dressing and preparation method thereof | |
Guan et al. | “All-in-one” tea polyphenol-modified injectable hyaluronic acid-based hydrogel for diabetic wound healing | |
Sorouri et al. | Enrichment of carbopol gel by natural peptide and clay for improving the burn wound repair process | |
CN107625992A (en) | A kind of soluble dressing and preparation method thereof | |
Yang et al. | Mussel-inspired near-infrared light-responsive gelatin-based hydrogels for enhancing MRSA-infected wound healing | |
CN114891279B (en) | Composite hydrogel and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |